Home Supplements How We Rate Blog
Type I Collagen (Collagen Alpha-1(I) chain)

Collagen Type I

Research reviewed: Up until 03/2026

Collagen Type I (Type I Collagen (Collagen Alpha-1(I) chain)) is a dietary supplement with 9 published peer-reviewed studies involving 1,820 participants, researched for Skin Elasticity & Hydration, Wound Healing, Bone Density and 1 more areas.

9
Studies
1,820
Participants
2014–2025
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Skin Elasticity & Hydration

Strong
4 studies 3 of 4 positive 1,299 participants 2 human

Wound Healing

Moderate
2 studies 1 of 2 positive 48 participants

Bone Density

Moderate
1 study 1 of 1 positive 131 participants

Anti-ageing

Moderate
2 studies 1 of 2 positive 114 participants 1 human

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

4/9
Randomised
5/9
Double-Blind
4/9
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2014)
69
Study 2 (2015)
105
Study 3 (2020)
0
Study 4 (2023)
1,125
Study 1 (2020)
40
Study 2 (2017)
8
Study 1 (2018)
131
Study 1 (2023)
114

Research Timeline

When the studies were published

1
2014
1
2015
1
2017
1
2018
2
2020
2
2023
1
2025

All Studies

Detailed breakdown of each trial. Click to expand.

Skin Elasticity & Hydration

1

To study the effectiveness of collagen hydrolysate (predominantly type I) on skin biophysical parameters related to cutaneous ageing.

2014 69 participants 8 weeks 2.5 g or 5.0 g/day collagen hydrolysate
Human Study Double-Blind Placebo Positive

Study Type

Double-blind, placebo-controlled RCT

Purpose

To study the effectiveness of collagen hydrolysate (predominantly type I) on skin biophysical parameters related to cutaneous ageing.

Dose

2.5 g or 5.0 g/day collagen hydrolysate

Participants

69 women aged 35-55

Duration

8 weeks

Results

Both doses significantly improved skin elasticity vs placebo. The 2.5 g dose showed a 7% increase in skin elasticity at 4 weeks. Effects persisted 4 weeks post-supplementation.

How They Measured It

Skin elasticity (Cutometer), periorbital wrinkle volume, TEWL

Read full study
2

To investigate the effect of oral collagen peptide supplementation on skin moisture and the dermal collagen network.

2015 105 participants 8 weeks 10 g/day collagen peptides
Human Study Double-Blind Placebo Positive

Study Type

Double-blind, placebo-controlled

Purpose

To investigate the effect of oral collagen peptide supplementation on skin moisture and the dermal collagen network.

Dose

10 g/day collagen peptides

Participants

105 women aged 40-60

Duration

8 weeks

Results

Oral collagen peptides significantly increased skin moisture and collagen density, and significantly reduced collagen fragmentation vs placebo. Effects maintained 4 weeks post-supplementation.

How They Measured It

Corneometry (skin hydration), high-resolution ultrasound (collagen density), reflectance confocal microscopy

Read full study
3

To review the mechanistic and clinical evidence for oral collagen supplementation (predominantly type I collagen) on skin health.

2020 ? participants Various Various (2.5–15 g/day)
Review/Other Mixed

Study Type

Systematic review and meta-analysis

Purpose

To review the mechanistic and clinical evidence for oral collagen supplementation (predominantly type I collagen) on skin health.

Dose

Various (2.5–15 g/day)

Participants

Multiple RCTs reviewed

Duration

Various

Results

Oral administration of intact or hydrolysed collagen improved skin elasticity, hydration, and dermal collagen density. Evidence was predominantly positive for type I collagen-enriched products.

How They Measured It

Synthesis of clinical outcomes across eligible RCTs — skin elasticity, hydration, collagen density

Read full study
4

To evaluate the effects of oral collagen on skin anti-ageing outcomes in a meta-analytical framework.

2023 1,125 participants 4–24 weeks Various
Review/Other Positive

Study Type

Systematic review and meta-analysis

Purpose

To evaluate the effects of oral collagen on skin anti-ageing outcomes in a meta-analytical framework.

Dose

Various

Participants

1,125 participants across 19 studies

Duration

4–24 weeks

Results

Collagen supplementation for up to 90 days resulted in significant improvements in skin elasticity, hydration, and wrinkle depth vs placebo.

How They Measured It

Pooled analysis of skin elasticity, hydration, wrinkles across 19 RCTs

Read full study

Wound Healing

1

To assess the effect of hydrolysed collagen supplementation on wound healing in burn patients.

2020 40 participants Until wound closure 1.5 g/day hydrolysed collagen
Human Study RCT Double-Blind Positive

Study Type

Randomised, double-blind pilot clinical trial

Purpose

To assess the effect of hydrolysed collagen supplementation on wound healing in burn patients.

Dose

1.5 g/day hydrolysed collagen

Participants

40 burn patients

Duration

Until wound closure

Results

Collagen supplementation resulted in a 3.7-fold greater hazard ratio of wound healing vs control (P=0.007). Serum albumin was significantly higher in the collagen group.

How They Measured It

Time to wound closure, serum albumin, hospital stay

Read full study
2

To assess vitamin C-enriched gelatin (type I collagen precursor) effect on collagen synthesis markers during intermittent exercise.

2017 8 participants 3 days 5, 15, or 48 g gelatin enriched with 48 mg vitamin C
Human Study RCT Mixed

Study Type

Randomised clinical trial

Purpose

To assess vitamin C-enriched gelatin (type I collagen precursor) effect on collagen synthesis markers during intermittent exercise.

Dose

5, 15, or 48 g gelatin enriched with 48 mg vitamin C

Participants

8 healthy males

Duration

3 days

Results

Gelatin supplementation dose-dependently increased serum P1NP. The 15 g dose doubled P1NP vs placebo. Proline, hydroxyproline, and hydroxylysine peaked 1 hour post-supplementation.

How They Measured It

Serum procollagen I N-terminal propeptide (P1NP), plasma amino acids

Read full study

Bone Density

1

To investigate whether specific collagen peptides derived from type I collagen improve bone mineral density in postmenopausal women with primary osteopenia.

2018 131 participants 12 months 5 g/day specific collagen peptides
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To investigate whether specific collagen peptides derived from type I collagen improve bone mineral density in postmenopausal women with primary osteopenia.

Dose

5 g/day specific collagen peptides

Participants

131 postmenopausal women with primary osteopenia

Duration

12 months

Results

Collagen peptides significantly increased BMD at spine and femur. Osteocalcin (bone formation) increased and CTX-1 (bone resorption) decreased, indicating net bone anabolism.

How They Measured It

DXA (lumbar spine and femoral neck BMD), serum osteocalcin, CTX-1

Read full study

Anti-ageing

1

To evaluate sustained effects of bioactive collagen peptides on skin ageing outcomes.

2023 114 participants 16 weeks 2.5 g/day bioactive collagen peptides
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate sustained effects of bioactive collagen peptides on skin ageing outcomes.

Dose

2.5 g/day bioactive collagen peptides

Participants

114 women aged 45-65

Duration

16 weeks

Results

Bioactive collagen peptides significantly improved skin elasticity and hydration throughout the 16-week trial. Wrinkle depth was significantly reduced. Improvements maintained during 4-week wash-out.

How They Measured It

Skin elasticity (Cutometer), skin moisture (Corneometry), wrinkle depth

Read full study
2

To evaluate whether collagen supplements prevent or treat skin ageing.

2025 ? participants Various Various (2.5–15 g/day)
Review/Other Mixed

Study Type

Systematic review and meta-analysis of RCTs

Purpose

To evaluate whether collagen supplements prevent or treat skin ageing.

Dose

Various (2.5–15 g/day)

Participants

Meta-analysis across multiple RCTs

Duration

Various

Results

Systematic review identified heterogeneous individual RCT results. While positive results for skin hydration and elasticity were noted, the 2025 meta-analysis called for larger standardised RCTs to confirm collagen's anti-ageing efficacy.

How They Measured It

Meta-analysis of skin elasticity, hydration, wrinkle data

Read full study

Frequently Asked Questions

Common questions about Collagen Type I research

What does the research say about Collagen Type I?

There are currently 9 peer-reviewed studies on Collagen Type I (Type I Collagen (Collagen Alpha-1(I) chain)), involving 1,820 total participants. Research covers Skin elasticity & hydration, Wound healing, Bone density and 1 more areas. The overall evidence strength is rated as Strong.

How strong is the evidence for Collagen Type I?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (6 human studies), and reported outcomes.

What health goals has Collagen Type I been studied for?

Collagen Type I has been researched for: Skin elasticity & hydration, Wound healing, Bone density, Anti-ageing. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Collagen Type I based on human trials?

Yes, 6 out of 9 studies are human trials. Human trials carry more weight in our evidence scoring system.